Iron - Deficiency Anemia Before Surgical Treatment And Its Correction Using Intravenous Iron Preparations
Objective of the study. To conduct systematic analysis of the data available in current literature on the effect of iron-deficiency anemia on the prognosis of cancer in case of surgical and therapeutic anti-tumor treatment. Materials and Methods. The overview includes the data of foreign and national articles on this subject found in Pubmed having been published over the last 10 years. Results. The possible mechanisms of the impact of iron-deficiency anemia on the development of post-operative complications in cancer patients as well as on the outcome of cancer treatment in general are described. Conclusion. Iron-deficiency is an independent factor of negative prognosis in case of surgical and therapeutic anti-tumor treatment. Administration of ferric carboxymaltose is an effective and safe method of correction of iron-deficiency anemia before elective surgical interventions including those performed for cancer treatment.